Clinical Trial Update: Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma [Phase 4]

View source ↗

Summary

Clinical trial update describing the phase 4 use evaluation of Triplenex, a triple fixed-combination glaucoma therapy, in glaucoma patients with active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Triplenex

Snippet

Sponsor: Federal University of São Paulo | Conditions: Glaucoma, Quality of Life (QOL) | Phase 4 | Status: ACTIVE_NOT_RECRUITING